13/05/2017 6o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών | V.Ninios | 1. MitraClip patient selection- what are the limits on good outcomes in FMR

 
1,012 VIEWS EXPANDCOLLAPSE PRESENTATION

Share

174,132 total
535 live
1,012 video
79,872 photo
Views:

09:00-11:00 Mitral club II
Πρόεδροι: S.Adamopoulos,G.Filippatos,A.Trikas
09:00-09:15 1. MitraClip patient selection- what are the limits on good outcomes in FMR
V.Ninios
09:15-09:30 2. MitraClip patient selection- what are the limits on good outcomes in DMR
M.Chrissoheris
09:30-09:45 3. Mitral interventions: a new challenge for structural interventionalists. How to learn mitral interventions
G.Pavlides
09:45-10:00 4. Surgical MV replacement and repair in FMR. State of the art (reality vs. the CTSNET and STICH-iMR trials)
P.Ponikowski
10:00-10:15 5. Innovation breaking news
K.Spargias
10:15-10:30 6. Which “operable” DMR patient I will opt for transcatheter therapy and why? Should we Surgeons make the first step this time?
S.Pattakos
10:30-10:45 7. Mitraclip case-in-a-box
K.Spargias
10:45-11:00 Συζήτηση


 
Sort by Date | Views
Watch live and on demand the '6th Conference of  Transcatheter Heart Valve Therapies'.
​
The Diagnostic and Therapeutic Center of Athens Hygeia organizes the '6th Conference of  Transcatheter Heart Valve Therapies' that will take place from 12 to 13 May 2017, at Hilton Hotel in Athens, Greece.

For more information please click here.

Παρακολουθήστε ζωντανά και on demand το '6ο Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών'.

Το Διαγνωστικό Θεραπευτικό Κέντρο Αθηνών ΥΓΕΙΑ διοργανώνει το '6o Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών' στις 12 - 13 Μαΐου 2017 στο ξενοδοχείο Hilton στην Αθήνα.

Για περισσότερες πληροφορίες, πατήστε εδώ.
A.Manginas | 1. The foundation of a new... 1.092
K.Spargias | 2. TAVR: The device evolution... 1.170
K.Toutouzas | 3. TAVR: The constantly changing... 997
G.Latsios | 4. What is the reasonable training... 1.094
K.Bellos | 5. What is the reasonable training... 1.016
A.Manolis | 6. Who should be performing... 1.718
I.Iakovou | 7. TAVI live case-in-a-box 1.229
S.Pattakos 959
460
D.Cokkinos 1.126
A.Kartapanis 941
I.Goudevenos 974
Στρατής Παττακός | Καρδιοχειρουργός, Διευθυντής... 1.211
1:24
Στέφανος Φούσας | Σ. Διευθυντής - Ε. Καθηγητής... 857
2:31
C.Mourmouris | 1. MSCT screening. Guidance,... 932
Catherine Avgeropoulou, Cardiologist, Director,... 1.009
1:49
Konstantinos Toutouzas | Associate Professor... 1.251
2:08
G.Latsios | 2. TF access today: vessel,... 904
Gregory Pavlides | MD, PhD, FACC, FESC, Professor... 1.046
2:08
N.Bouboulis | 3. Unanimous verdict: non... 918
V.Tzifos | 4. Concomitant coronary artery... 921
E.Skalidis | 5. The advanced renal failure... 1.035
K.Toutouzas | 6. The procedure was flawless... 998
K.Spargias | 7. TAVR live-in-a-box 1.022
C.Avgeropoulou | 1. A “Physiologist’s” view... 1.085
C.Chrysohoou | 2. From clinical practice... 1.042
G.Makos | 4. MR Surgery. When to repair... 1.038
G.Pavlides | 5. Trancatheter MV replacement.... 997
K.Spargias | 6. MAC and ViV, ViR 957
K.Spargias | 7. Mitraclip case-in-a-box 1.080
K.Spargias | 1. The “standardized” TAVR... 828
Konstantinos Spargias | Director, Transcatheter... 1.393
1:56
George Dangas | FESC, FACC, Professor of... 1.015
2:10
L.Papavasileiou | 2. Pacemaker need after... 945
A.Kostopoulou | 3. Pacemaker indication:... 1.179
J.Velianou | 4. Why I want to move to lower... 983
V. Andoutsopoulou | 5. What bothers me to... 1.238
G.Dangas | 6. Antiplatelet/anticoagulation... 1.076
C.Arampatzis | 7. My best and worst TAVR... 948
K.Raisakis | 1. My best and worst TAVR case... 1.099
V.Tzifos | 2. My best and worst TAVR case... 1.020
P.Davlouros | 3. My best and worst TAVR... 1.081
M.Ηamilos | 4. My best and worst TAVR case... 794
A.Zacharoulis | 5. My best and worst TAVR... 901
A.Synetos | 6. My best and worst TAVR case... 1.101
K.Papadopoulos | 8. My best and worst TAVR... 1.015
Andreas Synetos | MD, PhD, FESC, Cardiologist,... 1.028
1:24
V.Ninios | 1. MitraClip patient selection-... 1.012
V.Ninios | 1. MitraClip patient selection-... 954
G.Pavlides | 3. Mitral interventions: a... 985
S.Pattakos | 6. Which “operable” DMR patient... 952
V.Ninios | 7. Mitraclip case-in-a-box 839
M.Vavouranakis | 1. How I select my TAVR... 946
K.Spargias | 2. How I select my TAVR device?... 923
D.Nikas | 4. How I select my TAVR device?... 924
D.Nikas | 4. How I select my TAVR device?... 707
Q&A / Comments 910
K. Papadopoulos - K.Spargias | 6. TAVR live-in-a-box 966
A.Gkouziouta | 1. The pathophysiology of... 1.087
I.Ikonomidis | 2. Assessing Tricuspid Regurgitation:... 1.041
P.Sfyridis | 3. The unforgotten valve: what... 907
V.Sachpekidis | 5. The multiple valve disease... 1.020
V.Ninios | 6. Mitraclip in TR 864
M.Chrissoheris | 7. FORMA in TR 971
G.Stavridis | 8. The isolated TR inoperable... 989
Q&A / Comments 982
VIDEO UNDER EDITING - L.Michalis | 1. TAVR:... 1.047
D.Angouras | 2. TAVR device durability.... 1.003
L.Poulimenos | 3. Paradox AVS: implications... 1.134
P.Dardas | 4. TAVR in Bicuspid and ViV 907
I.Iakovou | 5. VARC-2 and MVRC definitions 1.018
G.Bompas | 6. The concept of 4D imaging... 1.012
D.Nikas | 7. My best and worst TAVR case... 807
A.Ziakas | 3. My best and worst TAVR case... 1.074
N.Pilatis | 1. My best and worst TAVR case... 793
G.Karavolias | 4. My best and worst TAVR... 1.000
K.Kalogeras | 5. My best and worst TAVR... 748
D.Tsikaderis | 6. My best and worst TAVR... 1.028
A.Manginas | 7. My best and worst TAVR case... 1.007
P. Kourkoveli | 2. My best and worst TAVR... 983
Christina Chrysohoou, MD, Cardiologist,Heart... 916
49
Irene Mastorakou, Cardiac Radiologist,Director,... 843
123
Lampros Michalis, Professor of Cardiology,University... 1.132
49
James Velianou, MD, FRCPC,Interventional... 1.000
69
Georgios Katsimagklis, InterventionalCardiologist,... 1.243
109